Flinn's vision is to make high-quality health products accessible for everyone. The first major milestone on this journey is to enable medical device manufacturers to automate quality and regulatory processes. The go-to-market product sets the focus on the automation of post-market surveillance processes. This means automating the collection, evaluation, and reporting of relevant data through smart workflows, integrations, and the support of AI.